All Stories

  1. Estimating Rupture Risk of Intracranial Aneurysms: What We Know, What We Do Not Know, and What We Need
  2. Appearance and Disappearance of Intracranial Aneurysm Wall Enhancement during Follow-Up: A Multicenter Cohort Study
  3. Proteomic Discovery Study of Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage
  4. Factors Affecting Outcomes Following Mini-Craniotomy Evacuation of Primary Chronic Subdural Hematoma: A Single-Center Retrospective Study
  5. Acetylsalicylic acid and subarachnoid hemorrhage in the Nurses’ Health Study
  6. Factors affecting outcomes following burr hole drainage of chronic subdural hematoma: a single-center retrospective study
  7. Cranial Nerve Palsies and Peri-Mesencephalic Subarachnoid Haemorrhage: A Case Report and Review of the Literature
  8. Computational fluid dynamics and shape analysis enhance aneurysm rupture risk stratification
  9. Clinical practice guidelines for the care of patients with a chronic subdural haematoma: multidisciplinary recommendations from presentation to recovery
  10. Microsurgical Treatment of Intracranial Dural Arteriovenous Fistulas: A Collaborative Investigation From the Multicenter Consortium for Dural Arteriovenous Fistula Outcomes Research
  11. Quantification of blood and CSF volume to predict outcome after aneurysmal subarachnoid hemorrhage
  12. Clinical practice guidelines for the care of patients with a chronic subdural haematoma: multidisciplinary recommendations from presentation to recovery
  13. A Randomised Controlled Trial of SFX-01 After Subarachnoid Haemorrhage — The SAS Study
  14. Cost-effectiveness of craniotomy versus decompressive craniectomy for UK patients with traumatic acute subdural haematoma
  15. Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE): a feasibility study and randomised, open, pragmatic, pilot phase trial
  16. Addressing barriers and identifying facilitators to support informed consent and recruitment in the Cavernous malformations A Randomised Effectiveness (CARE) pilot phase trial: insights from the integrated QuinteT recruitment intervention (QRI)
  17. Basilar artery perforator aneurysms: a comparison with non-perforator saccular aneurysms
  18. A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)
  19. Dural arteriovenous fistulas are not observed to convert to a higher grade after partial embolization
  20. Red Blood Cells in the Cerebrospinal Fluid Compartment After Subarachnoid Haemorrhage: Significance and Emerging Therapeutic Strategies
  21. A Systematic Review and Meta-Analysis of the Pathology Underlying Aneurysm Enhancement on Vessel Wall Imaging
  22. An assistive listening device improves hearing following aneurysmal subarachnoid haemorrhage
  23. Gadolinium-enhanced intracranial aneurysm wall imaging and risk of aneurysm growth and rupture: a multicentre longitudinal cohort study
  24. Dural Arteriovenous Fistulas With Cognitive Impairment: Angiographic Characteristics and Treatment Outcomes
  25. The Haptoglobin Response after Aneurysmal Subarachnoid Haemorrhage
  26. Risk of subarachnoid haemorrhage reduces with blood pressure values below hypertensive thresholds
  27. Functional effects of haemoglobin can be rescued by haptoglobin in an in vitro model of subarachnoid haemorrhage
  28. Protocol for the development of a multidisciplinary clinical practice guideline for the care of patients with chronic subdural haematoma
  29. Feasibility of comparing medical management and surgery (with neurosurgery or stereotactic radiosurgery) with medical management alone in people with symptomatic brain cavernoma – protocol for the Cavernomas: A Randomised Effectiveness (CARE) pilot trial
  30. Haptoglobin Treatment for Aneurysmal Subarachnoid Hemorrhage: Review and Expert Consensus on Clinical Translation
  31. Decompressive Craniectomy versus Craniotomy for Acute Subdural Hematoma
  32. Aneurysm management in patients over 80 years old with good grade subarachnoid haemorrhage
  33. The VEBAS score: a practical scoring system for intracranial dural arteriovenous fistula obliteration
  34. The association between acetylsalicylic acid and subarachnoid haemorrhage: the Framingham Heart Study
  35. Risk of Aneurysm Rupture (ROAR) study: protocol for a long-term, longitudinal, UK multicentre study of unruptured intracranial aneurysms
  36. Sphingosine-1-phosphate Signalling in Aneurysmal Subarachnoid Haemorrhage: Basic Science to Clinical Translation
  37. Time to evacuation of acute subdural and extradural haematoma: prospective study before and after implementation of a major trauma centre
  38. Age-related changes in tau and autophagy in human brain in the absence of neurodegeneration
  39. Functional effects of haemoglobin can be rescued by haptoglobin in anin vitromodel of subarachnoid haemorrhage
  40. Evidence-based interconversion of the Glasgow Outcome and modified Rankin scales: pitfalls and best practices
  41. Duration and characteristics of persistent headache following aneurysmal subarachnoid hemorrhage
  42. A Genome-Wide Association Study of Outcome After Aneurysmal Subarachnoid Haemorrhage: Discovery Analysis
  43. Radiological follow-up of endovascularly treated intracranial aneurysms: a survey of current practice in the UK and Ireland
  44. Genetic variation inNFE2L2is associated with outcome following aneurysmal subarachnoid haemorrhage
  45. Comparison of Suspected and Confirmed Internal External Ventricular Drain-Related Infections: A Prospective Multicenter United Kingdom Observational Study
  46. Long‐term fatigue following aneurysmal subarachnoid haemorrhage and the impact on employment
  47. Natural history, angiographic presentation and outcomes of anterior cranial fossa dural arteriovenous fistulas
  48. Aspirin and Subarachnoid Haemorrhage in the UK Biobank
  49. Evaluation of Outcomes Among Patients With Traumatic Intracranial Hypertension Treated With Decompressive Craniectomy vs Standard Medical Care at 24 Months
  50. Risk of Early Versus Later Rebleeding From Dural Arteriovenous Fistulas With Cortical Venous Drainage
  51. Iron Deposition in the Brain After Aneurysmal Subarachnoid Hemorrhage
  52. Assessing the rate, natural history, and treatment trends of intracranial aneurysms in patients with intracranial dural arteriovenous fistulas: a Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR) investigation
  53. Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR): rationale, design, and initial characterization of patient cohort
  54. Dural arteriovenous fistulas without cortical venous drainage: presentation, treatment, and outcomes
  55. Intervention for unruptured high-grade intracranial dural arteriovenous fistulas: a multicenter study
  56. Recurrence after cure in cranial dural arteriovenous fistulas: a collaborative effort by the Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR)
  57. Auditory outcome following aneurysmal subarachnoid haemorrhage
  58. Genome-Wide Association Study of Clinical Outcome After Aneurysmal Subarachnoid Haemorrhage: Protocol
  59. Pulsatile tympanic membrane displacement is associated with cognitive score in healthy subjects
  60. Long-Term Cognitive Outcome following Aneurysmal Subarachnoid Haemorrhage
  61. A survey of the radiological follow-up of unruptured intracranial aneurysms in the United Kingdom
  62. CRP (C-Reactive Protein) in Outcome Prediction After Subarachnoid Hemorrhage and the Role of Machine Learning
  63. Outcome Following Hemorrhage From Cranial Dural Arteriovenous Fistulae
  64. Estimating confidence intervals for cerebral autoregulation: a parametric bootstrap approach
  65. Utility of image-guided external ventriculostomy: analysis of contemporary practice in the United Kingdom and Ireland
  66. Psychological distress after subarachnoid haemorrhage: A systematic review and meta-analysis
  67. Age-related changes in Tau and Autophagy in human brain in the absence of neurodegeneration
  68. First Report of a Multicenter Prospective Registry of Cranioplasty in the United Kingdom and Ireland
  69. Validity of the Brief Test of Adult Cognition by Telephone in Level 1 Trauma Center Patients Six Months Post-Traumatic Brain Injury: A TRACK-TBI Study
  70. A meta-analysis of aspirin and subarachnoid hemorrhage in patients with intracranial aneurysms yields different results to the general population
  71. Onyx embolization for dural arteriovenous fistulas: a multi-institutional study
  72. Observation Versus Intervention for Low-Grade Intracranial Dural Arteriovenous Fistulas
  73. Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhage
  74. ANGPTL6 Genetic Variants Are an Underlying Cause of Familial Intracranial Aneurysms
  75. A vascular subtraction method for improving the variability of evoked tympanic membrane displacement measurements
  76. Neurofilament light predicts neurological outcome after subarachnoid haemorrhage
  77. Sonic Hedgehog Signaling Promotes Peri-Lesion Cell Proliferation and Functional Improvement after Cortical Contusion Injury
  78. Trial of Dexamethasone for Chronic Subdural Hematoma
  79. Author Correction: Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors
  80. Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors
  81. Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial
  82. Intracranial Masson Lesion Following Stereotactic Radiosurgery for Treatment of Intracranial Arteriovenous Malformations
  83. Assessment of the Subarachnoid Hemorrhage International Trialists (SAHIT) Models for Dichotomized Long-Term Functional Outcome Prediction After Aneurysmal Subarachnoid Hemorrhage in a United Kingdom Multicenter Cohort Study
  84. Age-Dependent Changes in Synaptic NMDA Receptor Composition in Adult Human Cortical Neurons
  85. Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT
  86. Study protocol for SFX-01 after subarachnoid haemorrhage (SAS): a multicentre randomised double-blinded, placebo controlled trial
  87. Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study
  88. Intracerebral implantation of human neural stem cells and motor recovery after stroke: multicentre prospective single-arm study (PISCES-2)
  89. Vasomotion Drives Periarterial Drainage of Aβ from the Brain
  90. Age dependent changes in synaptic NMDA receptor composition in adult human cortical neurons
  91. Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebo-controlled, randomised, double blind, multi-centre study
  92. Haptoglobin genotype and outcome after aneurysmal subarachnoid haemorrhage
  93. Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage
  94. Haemoglobin causes neuronal damage in vivo which is preventable by haptoglobin
  95. Clearance of interstitial fluid (ISF) and CSF (CLIC) group—part of Vascular Professional Interest Area (PIA)
  96. Time to surgery following chronic subdural hematoma: post hoc analysis of a prospective cohort study
  97. Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation
  98. Intracranial Hypertension and Cerebral Perfusion Pressure Insults in Adult Hypertensive Intraventricular Hemorrhage
  99. A primate-specific short GluN2A-NMDA receptor isoform is expressed in the human brain
  100. Vessel Wall Imaging After Subarachnoid Hemorrhage in Patients with Multiple Intracranial Aneurysms: A Cautionary Case
  101. Consensus statement from the International Consensus Meeting on the Role of Decompressive Craniectomy in the Management of Traumatic Brain Injury
  102. Neuroprotective Role of the Nrf2 Pathway in Subarachnoid Haemorrhage and Its Therapeutic Potential
  103. Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phase
  104. Haptoglobin genotype and aneurysmal subarachnoid hemorrhage
  105. Image guidance and improved accuracy of external ventricular drain tip position particularly in patients with small ventricles
  106. Current epidemiology of cerebrospinal fluid shunt surgery in the UK and Ireland (2004–2013)
  107. Correction to: Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial
  108. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial
  109. Safety, accuracy, and cost effectiveness of bedside bolt external ventricular drains (EVDs) in comparison to tunnelled EVDs inserted in theatres
  110. Influence of Antiplatelet and Anticoagulant Drug Use on Outcomes after Chronic Subdural Hematoma Drainage
  111. How is vasospasm screening using transcranial Doppler associated with delayed cerebral ischemia and outcomes in aneurysmal subarachnoid hemorrhage?
  112. Hearing impairment after subarachnoid hemorrhage
  113. SVM Optimization for Brain Tumor Identification Using Infrared Spectroscopic Samples
  114. Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial
  115. BRIDGING THE GAP – BENEFITS OF NEUROSURGICAL TISSUE FOR PRE-CLINICAL RESEARCH
  116. Pharmacological management of post-traumatic seizures in adults: current practice patterns in the UK and the Republic of Ireland
  117. Does Drain Position and Duration Influence Outcomes in Patients Undergoing Burr-Hole Evacuation of Chronic Subdural Hematoma? Lessons from a UK Multicenter Prospective Cohort Study
  118. Quantifying the contribution of intracranial pressure and arterial blood pressure to spontaneous tympanic membrane displacement
  119. Corrigendum to “Haptoglobin Genotype and Outcome after Subarachnoid Haemorrhage: New Insights from a Meta-Analysis”
  120. Haemoglobin scavenging in intracranial bleeding: biology and clinical implications
  121. Anatomy of spaces around blood vessels in cerebral amyloid angiopathy
  122. Outcomes following surgery in subgroups of comatose and very elderly patients with chronic subdural hematoma
  123. The Wessex modified Richmond Sedation Scale as a novel tool for monitoring patients at risk of malignant MCA syndrome
  124. Outcomes of Microsurgical Clipping of Recurrent Aneurysms After Endovascular Coiling
  125. Spatio-spectral classification of hyperspectral images for brain cancer detection during surgical operations
  126. Refining non-invasive techniques to measure intracranial pressure: comparing evoked and spontaneous tympanic membrane displacements
  127. A subarachnoid haemorrhage-specific outcome tool
  128. An Intraoperative Visualization System Using Hyperspectral Imaging to Aid in Brain Tumor Delineation
  129. An Evaluation of Commonly Used External Ventricular Drain Securement Methods in a Porcine Model: Recommendations to Improve Practice
  130. Reference intervals for the evoked tympanic membrane displacement measurement: a non-invasive measure of intracranial pressure
  131. Association of functional MMP-2 gene variant with intracranial aneurysms: case-control genetic association study and meta-analysis
  132. Does the Variability of Evoked Tympanic Membrane Displacement Data (V m) Increase as the Magnitude of the Pulse Amplitude Increases?
  133. Mentoring models in neurosurgical training: Review of literature
  134. Degree and Duration of Functional Improvement on Long-Term Follow-Up of Spinal Dural Arteriovenous Fistulae Occluded by Endovascular and Surgical Treatment
  135. The Resolution of Oculomotor Nerve Palsy Caused by Unruptured Posterior Communicating Artery Aneurysms: A Cohort Study and Narrative Review
  136. Prospective, multicentre study of external ventricular drainage-related infections in the UK and Ireland
  137. The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom
  138. CSF inflammatory response after intraventricular hemorrhage
  139. What Factors Determine Treatment Outcome in Aneurysmal Subarachnoid Hemorrhage in the Modern Era? A Post Hoc STASH Analysis
  140. Characteristics of Unruptured Compared to Ruptured Intracranial Aneurysms: A Multicenter Case–Control Study
  141. Cholesterol-Reducing Agents for Treatment of Aneurysmal Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis of Randomized Controlled Trials
  142. Compliance of systematic reviews articles in brain arteriovenous malformation with PRISMA statement guidelines: Review of literature
  143. P04.20 Hyperspectral imaging for brain tumour identification and boundaries delineation in real-time during neurosurgical operations
  144. Haptoglobin Genotype and Outcome after Subarachnoid Haemorrhage: New Insights from a Meta-Analysis
  145. Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension
  146. The effect of direction of force to the craniofacial skeleton on the severity of brain injury in patients with a fronto-basal fracture
  147. The use of human neurons for novel drug discovery in dementia research
  148. Heme–Hemopexin Scavenging Is Active in the Brain and Associates With Outcome After Subarachnoid Hemorrhage
  149. Elevated Baseline C-Reactive Protein as a Predictor of Outcome After Aneurysmal Subarachnoid Hemorrhage
  150. Pharmacologic Management of Subarachnoid Hemorrhage
  151. A Clinical Trial of Progesterone for Severe Traumatic Brain Injury
  152. Nitric Oxide Synthase Inhibition with the Antipterin VAS203 Improves Outcome in Moderate and Severe Traumatic Brain Injury: A Placebo-Controlled Randomized Phase IIa Trial (NOSTRA)
  153. External ventricular drainage: Is it time to look at national practice?
  154. Haemoglobin Scavenging After Subarachnoid Haemorrhage
  155. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial
  156. Alternative cost-effective method to record 3D intra-operative images: A technical note
  157. Proposal for establishment of the UK Cranial Reconstruction Registry (UKCRR)
  158. Recovery of oculomotor nerve palsy secondary to posterior communicating artery aneurysms
  159. A 73 Year-Old Man with a Mass at the Foramen Magnum
  160. Surgical management of acute subdural haematomas: current practice patterns in the United Kingdom and the Republic of Ireland
  161. A Randomized Controlled Trial of Prophylactic Intra-aortic Balloon Counterpulsation in High-Risk Aneurysmal Subarachnoid Hemorrhage
  162. Impairment of Cerebral Autoregulation Predicts Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
  163. The SILVER (Silver Impregnated Line Versus EVD Randomized Trial)
  164. A mathematical model of utility for single screening of asymptomatic unruptured intracranial aneurysms at the age of 50 years
  165. Pathological laughter and crying in patients with pontine lesions
  166. Response to: A web-based referral system for neurosurgery; a solution to our problems?
  167. The Natural History of Cranial Dural Arteriovenous Fistulae With Cortical Venous Reflux—The Significance of Venous Ectasia
  168. Neurenteric cyst of the anterior cranial fossa: case report and literature review
  169. Causes of neurological deficits following clipping of 200 consecutive ruptured aneurysms in patients with good-grade aneurysmal subarachnoid haemorrhage
  170. Chordoma of the anterior skull base presenting as a swelling of the medial canthus of the eye
  171. Placement of silicone sheeting at decompressive craniectomy to prevent adhesions at cranioplasty
  172. Visual recovery following optic nerve decompression for chronic compressive neuropathy
  173. A prospective study of the time to evacuate acute subdural and extradural haematomas
  174. An alternative method of wound pain control following hepatic resection: a preliminary study
  175. Activation of Ih is necessary for patterning of mGluR and mAChR induced network activity in the hippocampal CA3 region
  176. Opioid receptor regulation of muscarinic acetylcholine receptor-mediated synaptic responses in the hippocampus
  177. Regulation of muscarinic acetylcholine receptor-mediated synaptic responses by GABABreceptors in the rat hippocampus
  178. Coincident activation of mGluRs and mAChRs imposes theta frequency patterning on synchronised network activity in the hippocampal CA3 region
  179. Activation of nicotinic acetylcholine receptors patterns network activity in the rodent hippocampus